aluates Reports

$ 0.0

Automative

Global AI-based Clinical Trial Solution Market Research Report 2026

Published Date: 2026-01-14

Report Code: QYRE-Auto-30O5636

Global AI based Clinical Trial Solution Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global AI-based Clinical Trial Solution Market Research Report 2026

Code: QYRE-Auto-30O5636

Report

2026-01-14

Pages:132

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AiCure

Antidote

Deep Lens

Saama Technologies

Trials.ai

Deep 6 AI

Median Technologies

Mendel.ai

Phesi

IBM

Innoplexus

AI-based Clinical Trial Solution Market Size

The global AI-based Clinical Trial Solution market was valued at US$ 2715 million in 2025 and is anticipated to reach US$ 13122 million by 2032, at a CAGR of 25.2% from 2026 to 2032.

AI-based Clinical Trial Solution Market

AI-based Clinical Trial Solutions refer to the application of artificial intelligence and advanced analytics to optimize the design, execution, monitoring, and analysis of clinical trials across pharmaceutical, biotechnology, and medical device development. These solutions integrate machine learning, natural language processing, and real-world data analytics to improve protocol design, patient identification and recruitment, site feasibility assessment, risk-based monitoring, and endpoint analysis. By leveraging structured and unstructured data from electronic health records (EHRs), medical imaging, omics datasets, claims databases, and wearable or digital health sources, AI-based platforms enable faster trial initiation, higher patient enrollment efficiency, reduced protocol amendments, and improved statistical power. Commercially, these solutions are delivered as regulated GxP-compliant software, cloud-based SaaS platforms, or study-specific analytics services, and are increasingly embedded into decentralized and adaptive trial models, making them a core digital infrastructure component for modern clinical development.

The upstream segment of the industry chain consists of data sources and infrastructure providers, including EHR systems, imaging repositories, genomics platforms, cloud computing, and AI toolchains. Midstream players are AI clinical trial solution developers and platform providers that build validated analytics engines, regulatory-compliant software, and workflow integrations. Downstream customers primarily include pharmaceutical and biotechnology companies, contract research organizations (CROs), academic research centers, and, increasingly, digital health trial sponsors. Strategic partnerships between AI vendors and CROs or data holders are becoming a dominant commercialization pathway.

In terms of profitability, AI-based Clinical Trial Solutions typically exhibit higher gross margins than traditional CRO services. Mature SaaS or platform-based solutions can achieve gross margins in the range of approximately 50%–80%, driven by software scalability and recurring revenue models, while project-based or CRO-integrated AI services tend to show lower but improving margins, typically around 45–60%, due to higher labor and customization costs. Key market trends include accelerated adoption of decentralized and hybrid trials, growing regulatory acceptance of real-world data and synthetic control arms, increasing demand for patient stratification in precision medicine, and rising investment in end-to-end AI platforms that cover the full clinical trial lifecycle.

This report delivers a comprehensive overview of the global AI-based Clinical Trial Solution market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI-based Clinical Trial Solution. The AI-based Clinical Trial Solution market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI-based Clinical Trial Solution market comprehensively. Regional market sizes by Type, by Application, by Delivery & Commercial Model, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI-based Clinical Trial Solution manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AI-based Clinical Trial Solution Market Report

Report Metric	Details
Report Name	AI-based Clinical Trial Solution Market
Accounted market size in 2025	US$ 2715 million
Forecasted market size in 2032	US$ 13122 million
CAGR	25.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Artificial Narrow Intelligence Artificial General Intelligence Artificial Super Intelligence
Segment by Delivery & Commercial Model	On-device / Embedded AI Solutions Hybrid Edge–Cloud AI Platforms Others
Segment by Application	Drug Discovery Drug Manufacturing Drug Marketing Diagnosis and Treatment Clinical Trials
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies, Mendel.ai, Phesi, Tempus, IBM, Digital Reasoning, Insilico Medicine, Insitro, Evotec, PathAI, Cancer Center.ai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Delivery & Commercial Model, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI-based Clinical Trial Solution companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AI-based Clinical Trial Solution Market growing?

Ans: The AI-based Clinical Trial Solution Market witnessing a CAGR of 25.2% during the forecast period 2026-2032.

What is the AI-based Clinical Trial Solution Market size in 2032?

Ans: The AI-based Clinical Trial Solution Market size in 2032 will be US$ 13122 million.

Who are the main players in the AI-based Clinical Trial Solution Market report?

Ans: The main players in the AI-based Clinical Trial Solution Market are AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies, Mendel.ai, Phesi, Tempus, IBM, Digital Reasoning, Insilico Medicine, Insitro, Evotec, PathAI, Cancer Center.ai

What are the Application segmentation covered in the AI-based Clinical Trial Solution Market report?

Ans: The Applications covered in the AI-based Clinical Trial Solution Market report are Drug Discovery, Drug Manufacturing, Drug Marketing, Diagnosis and Treatment, Clinical Trials

What are the Type segmentation covered in the AI-based Clinical Trial Solution Market report?

Ans: The Types covered in the AI-based Clinical Trial Solution Market report are Artificial Narrow Intelligence, Artificial General Intelligence, Artificial Super Intelligence

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI-based Clinical Trial Solution Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Artificial Narrow Intelligence

1.2.3 Artificial General Intelligence

1.2.4 Artificial Super Intelligence

1.3 Market by Delivery & Commercial Model

1.3.1 Global AI-based Clinical Trial Solution Market Size Growth Rate by Delivery & Commercial Model: 2021 vs 2025 vs 2032

1.3.2 On-device / Embedded AI Solutions

1.3.3 Hybrid Edge–Cloud AI Platforms

1.3.4 Others

1.4 Market by Application

1.4.1 Global AI-based Clinical Trial Solution Market Growth by Application: 2021 vs 2025 vs 2032

1.4.2 Drug Discovery

1.4.3 Drug Manufacturing

1.4.4 Drug Marketing

1.4.5 Diagnosis and Treatment

1.4.6 Clinical Trials

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global AI-based Clinical Trial Solution Market Perspective (2021–2032)

2.2 Global AI-based Clinical Trial Solution Growth Trends by Region

2.2.1 Global AI-based Clinical Trial Solution Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI-based Clinical Trial Solution Historic Market Size by Region (2021–2026)

2.2.3 AI-based Clinical Trial Solution Forecasted Market Size by Region (2027–2032)

2.3 AI-based Clinical Trial Solution Market Dynamics

2.3.1 AI-based Clinical Trial Solution Industry Trends

2.3.2 AI-based Clinical Trial Solution Market Drivers

2.3.3 AI-based Clinical Trial Solution Market Challenges

2.3.4 AI-based Clinical Trial Solution Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI-based Clinical Trial Solution Players by Revenue

3.1.1 Global Top AI-based Clinical Trial Solution Players by Revenue (2021–2026)

3.1.2 Global AI-based Clinical Trial Solution Revenue Market Share by Players (2021–2026)

3.2 Global Top AI-based Clinical Trial Solution Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI-based Clinical Trial Solution Revenue

3.4 Global AI-based Clinical Trial Solution Market Concentration Ratio

3.4.1 Global AI-based Clinical Trial Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI-based Clinical Trial Solution Revenue in 2025

3.5 Global Key Players of AI-based Clinical Trial Solution Head Offices and Areas Served

3.6 Global Key Players of AI-based Clinical Trial Solution, Products and Applications

3.7 Global Key Players of AI-based Clinical Trial Solution, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AI-based Clinical Trial Solution Breakdown Data by Type

4.1 Global AI-based Clinical Trial Solution Historic Market Size by Type (2021–2026)

4.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Type (2027–2032)

5 AI-based Clinical Trial Solution Breakdown Data by Application

5.1 Global AI-based Clinical Trial Solution Historic Market Size by Application (2021–2026)

5.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AI-based Clinical Trial Solution Market Size (2021–2032)

6.2 North America AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI-based Clinical Trial Solution Market Size by Country (2021–2026)

6.4 North America AI-based Clinical Trial Solution Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI-based Clinical Trial Solution Market Size (2021–2032)

7.2 Europe AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI-based Clinical Trial Solution Market Size by Country (2021–2026)

7.4 Europe AI-based Clinical Trial Solution Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI-based Clinical Trial Solution Market Size (2021–2032)

8.2 Asia-Pacific AI-based Clinical Trial Solution Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2021–2026)

8.4 Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI-based Clinical Trial Solution Market Size (2021–2032)

9.2 Latin America AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI-based Clinical Trial Solution Market Size by Country (2021–2026)

9.4 Latin America AI-based Clinical Trial Solution Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI-based Clinical Trial Solution Market Size (2021–2032)

10.2 Middle East & Africa AI-based Clinical Trial Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021–2026)

10.4 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AiCure

11.1.1 AiCure Company Details

11.1.2 AiCure Business Overview

11.1.3 AiCure AI-based Clinical Trial Solution Introduction

11.1.4 AiCure Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.1.5 AiCure Recent Development

11.2 Antidote

11.2.1 Antidote Company Details

11.2.2 Antidote Business Overview

11.2.3 Antidote AI-based Clinical Trial Solution Introduction

11.2.4 Antidote Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.2.5 Antidote Recent Development

11.3 Deep Lens

11.3.1 Deep Lens Company Details

11.3.2 Deep Lens Business Overview

11.3.3 Deep Lens AI-based Clinical Trial Solution Introduction

11.3.4 Deep Lens Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.3.5 Deep Lens Recent Development

11.4 Saama Technologies

11.4.1 Saama Technologies Company Details

11.4.2 Saama Technologies Business Overview

11.4.3 Saama Technologies AI-based Clinical Trial Solution Introduction

11.4.4 Saama Technologies Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.4.5 Saama Technologies Recent Development

11.5 Trials.ai

11.5.1 Trials.ai Company Details

11.5.2 Trials.ai Business Overview

11.5.3 Trials.ai AI-based Clinical Trial Solution Introduction

11.5.4 Trials.ai Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.5.5 Trials.ai Recent Development

11.6 Deep 6 AI

11.6.1 Deep 6 AI Company Details

11.6.2 Deep 6 AI Business Overview

11.6.3 Deep 6 AI AI-based Clinical Trial Solution Introduction

11.6.4 Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.6.5 Deep 6 AI Recent Development

11.7 Innoplexus

11.7.1 Innoplexus Company Details

11.7.2 Innoplexus Business Overview

11.7.3 Innoplexus AI-based Clinical Trial Solution Introduction

11.7.4 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.7.5 Innoplexus Recent Development

11.8 Median Technologies

11.8.1 Median Technologies Company Details

11.8.2 Median Technologies Business Overview

11.8.3 Median Technologies AI-based Clinical Trial Solution Introduction

11.8.4 Median Technologies Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.8.5 Median Technologies Recent Development

11.9 Mendel.ai

11.9.1 Mendel.ai Company Details

11.9.2 Mendel.ai Business Overview

11.9.3 Mendel.ai AI-based Clinical Trial Solution Introduction

11.9.4 Mendel.ai Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.9.5 Mendel.ai Recent Development

11.10 Phesi

11.10.1 Phesi Company Details

11.10.2 Phesi Business Overview

11.10.3 Phesi AI-based Clinical Trial Solution Introduction

11.10.4 Phesi Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.10.5 Phesi Recent Development

11.11 Tempus

11.11.1 Tempus Company Details

11.11.2 Tempus Business Overview

11.11.3 Tempus AI-based Clinical Trial Solution Introduction

11.11.4 Tempus Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.11.5 Tempus Recent Development

11.12 IBM

11.12.1 IBM Company Details

11.12.2 IBM Business Overview

11.12.3 IBM AI-based Clinical Trial Solution Introduction

11.12.4 IBM Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.12.5 IBM Recent Development

11.13 Digital Reasoning

11.13.1 Digital Reasoning Company Details

11.13.2 Digital Reasoning Business Overview

11.13.3 Digital Reasoning AI-based Clinical Trial Solution Introduction

11.13.4 Digital Reasoning Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.13.5 Digital Reasoning Recent Development

11.14 Insilico Medicine

11.14.1 Insilico Medicine Company Details

11.14.2 Insilico Medicine Business Overview

11.14.3 Insilico Medicine AI-based Clinical Trial Solution Introduction

11.14.4 Insilico Medicine Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.14.5 Insilico Medicine Recent Development

11.15 Insitro

11.15.1 Insitro Company Details

11.15.2 Insitro Business Overview

11.15.3 Insitro AI-based Clinical Trial Solution Introduction

11.15.4 Insitro Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.15.5 Insitro Recent Development

11.16 Evotec

11.16.1 Evotec Company Details

11.16.2 Evotec Business Overview

11.16.3 Evotec AI-based Clinical Trial Solution Introduction

11.16.4 Evotec Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.16.5 Evotec Recent Development

11.17 PathAI

11.17.1 PathAI Company Details

11.17.2 PathAI Business Overview

11.17.3 PathAI AI-based Clinical Trial Solution Introduction

11.17.4 PathAI Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.17.5 PathAI Recent Development

11.18 Cancer Center.ai

11.18.1 Cancer Center.ai Company Details

11.18.2 Cancer Center.ai Business Overview

11.18.3 Cancer Center.ai AI-based Clinical Trial Solution Introduction

11.18.4 Cancer Center.ai Revenue in AI-based Clinical Trial Solution Business (2021–2026)

11.18.5 Cancer Center.ai Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AiCure

Antidote

Deep Lens

Saama Technologies

Trials.ai

Deep 6 AI

Median Technologies

Mendel.ai

Phesi

IBM

Innoplexus

List of Tables

Table 1. Global AI-based Clinical Trial Solution Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Artificial Narrow Intelligence

Table 3. Key Players of Artificial General Intelligence

Table 4. Key Players of Artificial Super Intelligence

Table 5. Global AI-based Clinical Trial Solution Market Size Growth Rate by Delivery & Commercial Model (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of On-device / Embedded AI Solutions

Table 7. Key Players of Hybrid Edge–Cloud AI Platforms

Table 8. Key Players of Others

Table 9. Key Players of Preclinical / Translational Analytics

Table 10. Key Players of Phase I (First-in-Human / Dose Finding)

Table 11. Key Players of Phase II (Proof-of-Concept)

Table 12. Key Players of Phase III (Pivotal Trials)

Table 13. Key Players of Phase IV / Post-Marketing (RWE)

Table 14. Global AI-based Clinical Trial Solution Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global AI-based Clinical Trial Solution Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global AI-based Clinical Trial Solution Market Size by Region (US$ Million), 2021–2026

Table 17. Global AI-based Clinical Trial Solution Market Share by Region (2021–2026)

Table 18. Global AI-based Clinical Trial Solution Forecasted Market Size by Region (US$ Million), 2027–2032

Table 19. Global AI-based Clinical Trial Solution Market Share by Region (2027–2032)

Table 20. AI-based Clinical Trial Solution Market Trends

Table 21. AI-based Clinical Trial Solution Market Drivers

Table 22. AI-based Clinical Trial Solution Market Challenges

Table 23. AI-based Clinical Trial Solution Market Restraints

Table 24. Global AI-based Clinical Trial Solution Revenue by Players (US$ Million), 2021–2026

Table 25. Global AI-based Clinical Trial Solution Market Share by Players (2021–2026)

Table 26. Global Top AI-based Clinical Trial Solution Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI-based Clinical Trial Solution Revenue, 2025

Table 27. Ranking of Global Top AI-based Clinical Trial Solution Companies by Revenue (US$ Million) in 2025

Table 28. Global 5 Largest Players Market Share by AI-based Clinical Trial Solution Revenue (CR5 and HHI), 2021–2026

Table 29. Global Key Players of AI-based Clinical Trial Solution, Headquarters and Area Served

Table 30. Global Key Players of AI-based Clinical Trial Solution, Products and Applications

Table 31. Global Key Players of AI-based Clinical Trial Solution, Date of General Availability (GA)

Table 32. Mergers and Acquisitions, Expansion Plans

Table 33. Global AI-based Clinical Trial Solution Market Size by Type (US$ Million), 2021–2026

Table 34. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2021–2026)

Table 35. Global AI-based Clinical Trial Solution Forecasted Market Size by Type (US$ Million), 2027–2032

Table 36. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2027–2032)

Table 37. Global AI-based Clinical Trial Solution Market Size by Application (US$ Million), 2021–2026

Table 38. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2021–2026)

Table 39. Global AI-based Clinical Trial Solution Forecasted Market Size by Application (US$ Million), 2027–2032

Table 40. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2027–2032)

Table 41. North America AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. North America AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2021–2026

Table 43. North America AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2027–2032

Table 44. Europe AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Europe AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2021–2026

Table 46. Europe AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2027–2032

Table 47. Asia-Pacific AI-based Clinical Trial Solution Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 48. Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (US$ Million), 2021–2026

Table 49. Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (US$ Million), 2027–2032

Table 50. Latin America AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 51. Latin America AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2021–2026

Table 52. Latin America AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2027–2032

Table 53. Middle East & Africa AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 54. Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2021–2026

Table 55. Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (US$ Million), 2027–2032

Table 56. AiCure Company Details

Table 57. AiCure Business Overview

Table 58. AiCure AI-based Clinical Trial Solution Product

Table 59. AiCure Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 60. AiCure Recent Development

Table 61. Antidote Company Details

Table 62. Antidote Business Overview

Table 63. Antidote AI-based Clinical Trial Solution Product

Table 64. Antidote Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 65. Antidote Recent Development

Table 66. Deep Lens Company Details

Table 67. Deep Lens Business Overview

Table 68. Deep Lens AI-based Clinical Trial Solution Product

Table 69. Deep Lens Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 70. Deep Lens Recent Development

Table 71. Saama Technologies Company Details

Table 72. Saama Technologies Business Overview

Table 73. Saama Technologies AI-based Clinical Trial Solution Product

Table 74. Saama Technologies Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 75. Saama Technologies Recent Development

Table 76. Trials.ai Company Details

Table 77. Trials.ai Business Overview

Table 78. Trials.ai AI-based Clinical Trial Solution Product

Table 79. Trials.ai Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 80. Trials.ai Recent Development

Table 81. Deep 6 AI Company Details

Table 82. Deep 6 AI Business Overview

Table 83. Deep 6 AI AI-based Clinical Trial Solution Product

Table 84. Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 85. Deep 6 AI Recent Development

Table 86. Innoplexus Company Details

Table 87. Innoplexus Business Overview

Table 88. Innoplexus AI-based Clinical Trial Solution Product

Table 89. Innoplexus Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 90. Innoplexus Recent Development

Table 91. Median Technologies Company Details

Table 92. Median Technologies Business Overview

Table 93. Median Technologies AI-based Clinical Trial Solution Product

Table 94. Median Technologies Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 95. Median Technologies Recent Development

Table 96. Mendel.ai Company Details

Table 97. Mendel.ai Business Overview

Table 98. Mendel.ai AI-based Clinical Trial Solution Product

Table 99. Mendel.ai Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 100. Mendel.ai Recent Development

Table 101. Phesi Company Details

Table 102. Phesi Business Overview

Table 103. Phesi AI-based Clinical Trial Solution Product

Table 104. Phesi Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 105. Phesi Recent Development

Table 106. Tempus Company Details

Table 107. Tempus Business Overview

Table 108. Tempus AI-based Clinical Trial Solution Product

Table 109. Tempus Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 110. Tempus Recent Development

Table 111. IBM Company Details

Table 112. IBM Business Overview

Table 113. IBM AI-based Clinical Trial Solution Product

Table 114. IBM Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 115. IBM Recent Development

Table 116. Digital Reasoning Company Details

Table 117. Digital Reasoning Business Overview

Table 118. Digital Reasoning AI-based Clinical Trial Solution Product

Table 119. Digital Reasoning Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 120. Digital Reasoning Recent Development

Table 121. Insilico Medicine Company Details

Table 122. Insilico Medicine Business Overview

Table 123. Insilico Medicine AI-based Clinical Trial Solution Product

Table 124. Insilico Medicine Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 125. Insilico Medicine Recent Development

Table 126. Insitro Company Details

Table 127. Insitro Business Overview

Table 128. Insitro AI-based Clinical Trial Solution Product

Table 129. Insitro Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 130. Insitro Recent Development

Table 131. Evotec Company Details

Table 132. Evotec Business Overview

Table 133. Evotec AI-based Clinical Trial Solution Product

Table 134. Evotec Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 135. Evotec Recent Development

Table 136. PathAI Company Details

Table 137. PathAI Business Overview

Table 138. PathAI AI-based Clinical Trial Solution Product

Table 139. PathAI Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 140. PathAI Recent Development

Table 141. Cancer Center.ai Company Details

Table 142. Cancer Center.ai Business Overview

Table 143. Cancer Center.ai AI-based Clinical Trial Solution Product

Table 144. Cancer Center.ai Revenue in AI-based Clinical Trial Solution Business (US$ Million), 2021–2026

Table 145. Cancer Center.ai Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. AI-based Clinical Trial Solution Picture

Figure 2. Global AI-based Clinical Trial Solution Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AI-based Clinical Trial Solution Market Share by Type: 2025 vs 2032

Figure 4. Artificial Narrow Intelligence Features

Figure 5. Artificial General Intelligence Features

Figure 6. Artificial Super Intelligence Features

Figure 7. Global AI-based Clinical Trial Solution Market Size Comparison by Delivery & Commercial Model (US$ Million), 2021–2032

Figure 8. On-device / Embedded AI Solutions Features

Figure 9. Hybrid Edge–Cloud AI Platforms Features

Figure 10. Others Features

Figure 11. Preclinical / Translational Analytics Features

Figure 12. Phase I (First-in-Human / Dose Finding) Features

Figure 13. Phase II (Proof-of-Concept) Features

Figure 14. Phase III (Pivotal Trials) Features

Figure 15. Phase IV / Post-Marketing (RWE) Features

Figure 16. Global AI-based Clinical Trial Solution Market Size by Application (US$ Million), 2021–2032

Figure 17. Global AI-based Clinical Trial Solution Market Share by Application: 2025 vs 2032

Figure 18. Drug Discovery Case Studies

Figure 19. Drug Manufacturing Case Studies

Figure 20. Drug Marketing Case Studies

Figure 21. Diagnosis and Treatment Case Studies

Figure 22. Clinical Trials Case Studies

Figure 23. AI-based Clinical Trial Solution Report Years Considered

Figure 24. Global AI-based Clinical Trial Solution Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 25. Global AI-based Clinical Trial Solution Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 26. Global AI-based Clinical Trial Solution Market Share by Region: 2025 vs 2032

Figure 27. Global AI-based Clinical Trial Solution Market Share by Players in 2025

Figure 28. Global AI-based Clinical Trial Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. The Top 10 and 5 Players Market Share by AI-based Clinical Trial Solution Revenue in 2025

Figure 30. North America AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. North America AI-based Clinical Trial Solution Market Share by Country (2021–2032)

Figure 32. United States AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Canada AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Europe AI-based Clinical Trial Solution Market Share by Country (2021–2032)

Figure 36. Germany AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. France AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. U.K. AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Italy AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Russia AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Ireland AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Asia-Pacific AI-based Clinical Trial Solution Market Share by Region (2021–2032)

Figure 44. China AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Japan AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. South Korea AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Southeast Asia AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. India AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Australia & New Zealand AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Latin America AI-based Clinical Trial Solution Market Share by Country (2021–2032)

Figure 52. Mexico AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Brazil AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Middle East & Africa AI-based Clinical Trial Solution Market Share by Country (2021–2032)

Figure 56. Israel AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Saudi Arabia AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. UAE AI-based Clinical Trial Solution Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. AiCure Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 60. Antidote Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 61. Deep Lens Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 62. Saama Technologies Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 63. Trials.ai Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 64. Deep 6 AI Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 65. Innoplexus Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 66. Median Technologies Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 67. Mendel.ai Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 68. Phesi Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 69. Tempus Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 70. IBM Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 71. Digital Reasoning Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 72. Insilico Medicine Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 73. Insitro Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 74. Evotec Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 75. PathAI Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 76. Cancer Center.ai Revenue Growth Rate in AI-based Clinical Trial Solution Business (2021–2026)

Figure 77. Bottom-up and Top-down Approaches for This Report

Figure 78. Data Triangulation

Figure 79. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global AI In Clinical Trials Market Research Report 2024

Global Intelligent Clinical Trials Market Research Report 2024

Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030

Global Artificial Intelligence AI in Cancer Market Research Report 2024

Medical AI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI for Pharma and Biotech Market Insights Forecast to 2030

AI driven Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical AI Data Analysis Market Research Report 2024

Global AI based Antibody Development Platform Market Research Report 2024

Artificial Intelligence driven Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Healthcare Artificial Intelligence Market

Global AI Financial Solution Market Research Report 2024

AI Solutions for Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artificial Intelligence Based Software for Radiology Market Research Report 2025

Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI In Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Solutions Market Research Report 2024

AI Healthcare Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI In Diagnostic Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions